Company intelligence / Profile preview

LabLogic Systems

Sheffield, South Yorkshire, United Kingdom

Ownership: Private
Development stage: Other

Overview

LabLogic Systems is a leading provider of instrumentation and software for radioactivity detection and measurement, supporting PET production, QC of radiopharmaceuticals, theranostics R&D, and environmental studies; it has a significant market share in pharmaceutical research, nuclear medicine, and cancer research, with growing involvement in theranostic workflows and partnerships with academic consortia.[1][4][5]

Therapeutic areas: OncologyOther
Modalities: DeviceSoftwareRadiopharmaceutical
Industry: Drug Discovery Services

Partnerships

University of YorkKing’s College LondonEuropean consortia (QC for theranostics)

Beyond the preview

Go deeper on LabLogic Systems.

Explore clinical development, deal activity, and the competitive landscape with Gosset’s full data platform.

Clinical trials

Follow clinical development from trial design and recruitment through results.

Trial phase
Status
Readouts

Licensing & deals

Explore licensing agreements, acquisitions, and the assets behind each deal.

Partners
Deal terms
Milestones

Funding history

Trace financing activity and the investors behind a company’s development.

Funding rounds
Investors
Capital raised

Competitive landscape

Compare peer pipelines by target, modality, and therapeutic area.

Peer companies
Targets
Pipeline overlap

Technologies & patents

Explore technology platforms and the patent landscape around relevant assets.

Platforms
Patents
Assignees

Research & analysis

Connect company news and source material to the questions you’re investigating.

Company news
Sources
Analysis

Bring the full picture into focus.

See how Gosset can support your research on LabLogic Systems.

Explore the full profile